Beneficial effect of gemfibrozil on the chemical composition and oxidative susceptibility of low density lipoprotein: a randomized, double-blind, placebo-controlled study
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 139 (1) , 179-187
- https://doi.org/10.1016/s0021-9150(98)00062-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapyAtherosclerosis, 1994
- Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern BThe American Journal of Medicine, 1993
- Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspeciesAtherosclerosis, 1992
- Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in manThe Lancet, 1992
- Low density lipoprotein particle size and coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Role of oxidized low density lipoprotein in atherogenesis.Journal of Clinical Investigation, 1991
- Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.Circulation, 1990
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987